Omega-3 fatty acid intake suppresses induction of diverse autoantibody repertoire by crystalline silica in lupus-prone mice

References

• Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526–1533.
   PubMed Web of Science ®Google Scholar
• Eriksson C, Kokkonen H, Johansson M, et al. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther. 2011;13:R30.
   PubMed Web of Science ®Google Scholar
• Sherer Y, Gorstein A, Fritzler MJ, et al. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004;34:501–537.
   PubMed Web of Science ®Google Scholar
• Sterner RM, Hartono SP, Grande JP. The pathogenesis of lupus nephritis. J Clin Cell Immunol. 2014;5:205.
   PubMedGoogle Scholar
• Cross LS, Aslam A, Misbah SA. Antinuclear antibody-negative lupus as a distinct diagnostic entity-does it no longer exist? QJM. 2004;97:303–308.
   PubMed Web of Science ®Google Scholar
• Yaniv G, Twig G, Shor DB, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 2015;14:75–79.
   PubMed Web of Science ®Google Scholar
• Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71:1400–1412.
   PubMed Web of Science ®Google Scholar
• Luo H, Wang L, Bao D, et al. Novel autoantibodies related to cell death and DNA repair pathways in systemic lupus erythematosus. Gen Prot Bioinform. 2019;17:248–259.
   PubMed Web of Science ®Google Scholar
• Parks CG, Cooper GS, Nylander-French LA, et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum. 2002;46:1840–1850.
   PubMed Web of Science ®Google Scholar
• Pollard KM. Silica, silicosis, and autoimmunity [perspective]. Front Immunol. 2016;7:97.
   PubMed Web of Science ®Google Scholar
• Brown J, Archer A, Pfau J, et al. Silica accelerated systemic autoimmune disease in lupus‐prone New Zealand mixed mice. Clin Exp Immunol. 2003;131:415–421.
   PubMed Web of Science ®Google Scholar
• Brown JM, Pfau JC, Holian A. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal Toxicol. 2004;16:133–139.
   PubMed Web of Science ®Google Scholar
• Bates MA, Brandenberger C, Langohr I, et al. Silica triggers inflammation and ectopic lymphoid neogenesis in the lungs in parallel with accelerated onset of systemic autoimmunity and glomerulonephritis in the lupus-prone NZBWF1 mouse. PLoS One. 2015;10:e0125481.
   PubMed Web of Science ®Google Scholar
• Benninghoff AD, Bates MA, Chauhan PS, et al. Docosahexaenoic acid consumption impedes early interferon- and chemokine-related gene expression while suppressing silica-triggered flaring of murine lupus. Front Immunol. 2019;10:2851.
   PubMed Web of Science ®Google Scholar
• Wierenga KA, Harkema JR, Pestka JJ. Lupus, silica, and dietary omega-3 fatty acid interventions. Toxicol Pathol. 2019;47:1004–1011.
   PubMed Web of Science ®Google Scholar
• Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45:1105–1115.
   PubMed Web of Science ®Google Scholar
• Ferreira HB, Pereira AM, Melo T, et al. Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus. J Pharm Biomed Anal. 2019;174:386–395.
   PubMed Web of Science ®Google Scholar
• Pestka JJ. n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis. Prostaglandins Leukot Essent Fatty Acids. 2010;82:251–258.
   PubMed Web of Science ®Google Scholar
• Akbar U, Yang M, Kurian D, et al. Omega-3 fatty acids in rheumatic diseases: a critical review. J Clin Rheumatol. 2017;23:330–339.
   PubMed Web of Science ®Google Scholar
• Fenton JI, Gurzell EA, Davidson EA, et al. Red blood cell PUFAs reflect the phospholipid PUFA composition of major organs. Prostaglandins Leukot Essent Fatty Acids. 2016;112:12–23.
   PubMed Web of Science ®Google Scholar
• Wierenga KA, Strakovsky RS, Benninghoff AD, et al. Requisite omega-3 HUFA biomarker thresholds for preventing murine lupus flaring. Front Immunol. 2020;11:1796.
   Google Scholar
• Aghdassi E, Ma DWL, Morrison S, et al. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study. JPEN J Parenter Enteral Nutr. 2011;35:198–208.
   PubMed Web of Science ®Google Scholar
• Elkan AC, Anania C, Gustafsson T, et al. Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis. Lupus. 2012;21:1405–1411.
   PubMed Web of Science ®Google Scholar
• Charoenwoodhipong P, Harlow SD, Marder W, et al. Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance (MILES) Program. Arthr Care Res (Hoboken). 2020;72:874–881.
   PubMed Web of Science ®Google Scholar
• Pestka JJ, Vines LL, Bates MA, et al. Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse. PLoS One. 2014;9:e100255.
   PubMed Web of Science ®Google Scholar
• Bates MA, Brandenberger C, Langohr II, et al. Silica-triggered autoimmunity in lupus-prone mice blocked by docosahexaenoic acid consumption. PLoS One. 2016;11:e0160622.
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Lawrence RA, Krishnan A, et al. Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice. J Am Coll Nutr. 2003;22:388–399.
   PubMed Web of Science ®Google Scholar
• Chandrasekar B, Troyer DA, Venkatraman JT, et al. Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression. J Autoimmun. 1995;8:381–393.
   PubMed Web of Science ®Google Scholar
• Halade GV, Williams PJ, Veigas JM, et al. Concentrated fish oil (Lovaza(R)) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice. Exp Biol Med (Maywood). 2013;238:610–622.
   PubMed Web of Science ®Google Scholar
• Halade GV, Rahman MM, Bhattacharya A, et al. Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice. J Immunol. 2010;184:5280–5286.
   PubMed Web of Science ®Google Scholar
• Bates M, Akbari P, Gilley K, et al. Dietary docosahexaenoic acid prevents silica-induced development of pulmonary ectopic germinal centers and glomerulonephritis in the lupus-prone NZBWF1 mouse. Front Immunol. 2018;9:2002.
   PubMed Web of Science ®Google Scholar
• Joshi GN, Gilberti RM, Knecht DA. Single cell analysis of phagocytosis, phagosome maturation, phagolysosomal leakage, and cell death following exposure of macrophages to silica particles. Meth Mol Biol. 2017;1519:55–77.
   PubMedGoogle Scholar
• Desai J, Foresto-Neto O, Honarpisheh M, et al. Particles of different sizes and shapes induce neutrophil necroptosis followed by the release of neutrophil extracellular trap-like chromatin. Sci Rep. 2017;7:15003.
   PubMed Web of Science ®Google Scholar
• Hamilton RF, Jr., Thakur SA, Mayfair JK, et al. MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. J Biol Chem. 2006;281:34218–34226.
   PubMed Web of Science ®Google Scholar
• Wierenga KA, Wee J, Gilley KN, et al. Docosahexaenoic acid suppresses silica-induced inflammasome activation and IL-1 cytokine release by interfering with priming signal. Front Immunol. 2019;10:2130.
   Google Scholar
• Rajasinghe LD, Chauhan PS, Wierenga KA, et al. Omega-3 docosahexaenoic acid (DHA) impedes silica-induced macrophage corpse accumulation by attenuating cell death and potentiating efferocytosis. Front Immunol. 2020;11:2179.
   Google Scholar
• Lescoat A, Ballerie A, Lelong M, et al. Crystalline silica impairs efferocytosis abilities of human and mouse macrophages: implication for silica-associated systemic sclerosis. Front Immunol. 2020;11:219.
   PubMed Web of Science ®Google Scholar
• Zhu H, Luo H, Yan M, et al. Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus. Genom Prot Bioinform. 2015;13:210–218.
   PubMed Web of Science ®Google Scholar
• Chong BF, Tseng LC, Lee T, et al. IgG and IgM autoantibody differences in discoid and systemic lupus patients. J Invest Dermatol. 2012;132:2770–2779.
   PubMed Web of Science ®Google Scholar
• van der Meulen PM, Barendregt AM, Cuadrado E, et al. Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus. Rheumatol. 2017;56:1407–1416.
   PubMed Web of Science ®Google Scholar
• Li QZ, Zhou J, Lian Y, et al. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol. 2010;159:281–291.
   PubMed Web of Science ®Google Scholar
• Li QZ, Xie C, Wu T, et al. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest. 2005;115:3428–3439.
   PubMed Web of Science ®Google Scholar
• Reeves WH, Lee PY, Weinstein JS, et al. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009;30:455–464.
   PubMed Web of Science ®Google Scholar
• Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015;43:W566–W570.
   PubMed Web of Science ®Google Scholar
• Quail MT. Overview of silica-related clusters in the United States: will fracking operations become the next cluster? J Environ Health. 2017;79:20–27.
   PubMed Web of Science ®Google Scholar
• Bello A, Mugford C, Murray A, et al. Characterization of occupational exposures to respirable silica and dust in demolition, crushing, and chipping activities. Ann Work Expos Health. 2019;63:34–44.
   PubMed Web of Science ®Google Scholar
• Miller FW, Alfredsson L, Costenbader KH, et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun. 2012;39:259–271.
   PubMed Web of Science ®Google Scholar
• Parks CG, de Souza Espindola Santos A, Barbhaiya M, et al. Understanding the role of environmental factors in the development of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2017;31:306–320.
   PubMed Web of Science ®Google Scholar
• Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect. 1999;107(Suppl 5):793–802.
   PubMed Web of Science ®Google Scholar
• Vacek PM, Hemenway DR, Absher MP, et al. The translocation of inhaled silicon dioxide: an empirically derived compartmental model. Fund Appl Toxicol. 1991;17:614–626.
   PubMedGoogle Scholar
• Ceppellini R, Polli E, Celada F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med. 1957;96:572–574.
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthr Rheum. 2012;64:2677–2686.
   PubMed Web of Science ®Google Scholar
• Reeves WH. Antibodies to the p70/p80 (Ku) antigens in systemic lupus erythematosus. Rheum Dis Clin North Am. 1992;18:391–414.
   PubMed Web of Science ®Google Scholar
• Greidinger EL, Hoffman RW. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1–70 kd and B′/B proteins as predominant U1 RNP immunogens. Arthr Rheum. 2001;44:368–375.
   PubMed Web of Science ®Google Scholar
• Cozzani E, Drosera M, Gasparini G, et al. Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Dis. 2014;2014:321359.
   PubMedGoogle Scholar
• Cutter AR, Hayes JJ. A brief review of nucleosome structure. FEBS Lett. 2015;589:2914–2922.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486–541.
   PubMed Web of Science ®Google Scholar
• McClain M, Scofield R, Kurien B, et al. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE. Scand J Immunol. 2002;56:399–407.
   PubMed Web of Science ®Google Scholar
• Elkon KB, Parnassa AP, Foster CL. Lupus autoantibodies target ribosomal P proteins. J Exp Med. 1985;162:459–471.
   PubMed Web of Science ®Google Scholar
• Harley JB, Alexander EL, Bias WB, et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren’s syndrome. Arthritis Rheum. 1986;29:196–206.
   PubMed Web of Science ®Google Scholar
• Alba P, Bento L, Cuadrado M, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis. 2003;62:556–560.
   PubMed Web of Science ®Google Scholar
• Sen D, Isenberg DA. Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus. 2003;12:651–658.
   PubMed Web of Science ®Google Scholar
• Haddon DJ, Diep VK, Price JV, et al. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus. Arthr ResTher. 2015;17:162–162.
   Google Scholar
• Trendelenburg M, Lopez-Trascasa M, Potlukova E, et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant. 2006;21:3115–3121.
   PubMed Web of Science ®Google Scholar
• Dragon-Durey MA, Blanc C, Marinozzi MC, et al. Autoantibodies against complement components and functional consequences. Mol Immunol. 2013;56:213–221.
   PubMed Web of Science ®Google Scholar
• Yahya A, Bengtsson C, Larsson P, et al. Silica exposure is associated with an increased risk of developing ACPA-positive rheumatoid arthritis in an Asian population: evidence from the Malaysian MyEIRA case-control study. Mod Rheumatol. 2014;24:271–274.
   PubMed Web of Science ®Google Scholar
• Ilar A, Klareskog L, Saevarsdottir S, et al. Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study. RMD Open. 2019;5:e000978.
   PubMed Web of Science ®Google Scholar
• Vihlborg P, Bryngelsson IL, Andersson L, et al. Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: a retrospective cohort study. BMJ Open. 2017;7:e016839.
   PubMed Web of Science ®Google Scholar
• De Decker E, Vanthuyne M, Blockmans D, et al. High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis. Clin Rheumatol. 2018;37:1977–1982.
   PubMed Web of Science ®Google Scholar
• Englert H, Small-McMahon J, Davis K, et al. Male systemic sclerosis and occupational silica exposure-a population-based study. Aust N Z J Med. 2000;30:215–220.
   PubMedGoogle Scholar
• Rubio-Rivas M, Moreno R, Corbella X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol. 2017;36:569–582.
   PubMed Web of Science ®Google Scholar
• Gomez-Puerta JA, Gedmintas L, Costenbader KH. The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis. Autoimmun Rev. 2013;12:1129–1135.
   PubMed Web of Science ®Google Scholar
• Makol A, Reilly MJ, Rosenman KD. Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med. 2011;54:255–262.
   PubMed Web of Science ®Google Scholar
• Martucciello S, Paolella G, Esposito C, et al. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease. Cell Mol Life Sci. 2018;75:4107–4124.
   PubMed Web of Science ®Google Scholar
• Trouw LA, Mahler M. Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis. Autoimmun Rev. 2012;12:318–322.
   PubMed Web of Science ®Google Scholar
• Murakami K, Mimori T. Recent advances in research regarding autoantibodies in connective tissue diseases and related disorders. Intern Med. 2019;58:5–14.
   PubMed Web of Science ®Google Scholar
• Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016;280:8–23.
   PubMed Web of Science ®Google Scholar
• Muratori L, Deleonardi G, Lalanne C, et al. Autoantibodies in autoimmune hepatitis. Dig Dis. 2015;33:65–69.
   PubMed Web of Science ®Google Scholar
• Casali P. IgM. In: Delves PJ, editor. Encyclopedia of immunology. 2nd ed. Oxford: Elsevier; 1998. p. 1212–1217.
   Google Scholar
• Korganow AS, Ji H, Mangialaio S, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 1999;10:451–461.
   PubMed Web of Science ®Google Scholar
• Vaughan JH. 1992 Joseph J. Bunim Lecture. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis Rheum. 1993;36:1–6.
   PubMedGoogle Scholar
• Wu MY, Chen CS, Yiang GT, et al. The emerging role of pathogenesis of IgA nephropathy. J Clin Med 2018;7:225.
   Google Scholar
• Hongyan L, Yi Z, Bao D, et al. A study on clinical and pathologic features in lupus nephritis with mainly IgA deposits and a literature review. Clin Dev Immunol. 2013;2013:1–5.
   Google Scholar
• Jost SA, Tseng LC, Matthews LA, et al. IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients. ScientificWorldJournal. 2014;2014:171028.
   PubMedGoogle Scholar
• Villalta D, Bizzaro N, Bassi N, et al. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS One. 2013;8:e71458.
   PubMed Web of Science ®Google Scholar
• Li QZ, Zhao HJ, Yan M, et al. Profiling autoreactive IgA antibodies against 124 autoantigens in Systemic lupus erythematosus, systemic scleroderma and idiopathic inflammatory myositis. J Immunol. 2016;196:209.9.
   Web of Science ®Google Scholar
• Wong SW, Kwon MJ, Choi AM, et al. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem. 2009;284:27384–27392.
   PubMed Web of Science ®Google Scholar
• Norris PC, Dennis EA. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc Natl Acad Sci USA. 2012;109:8517–8522.
   PubMed Web of Science ®Google Scholar
• Norris PC, Gosselin D, Reichart D, et al. Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. Proc Natl Acad Sci USA. 2014;111:12746–12751.
   PubMed Web of Science ®Google Scholar
• Li X, Yu Y, Funk CD. Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4). FASEB J. 2013;27:4987–4997.
   PubMed Web of Science ®Google Scholar
• Yan Y, Jiang W, Spinetti T, et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38:1154–1163.
   PubMed Web of Science ®Google Scholar
• Ricote M, Glass CK. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta. 2007;1771:926–935.
   PubMed Web of Science ®Google Scholar
• Chang HY, Lee HN, Kim W, et al. Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor γ activation. Life Sci. 2015;120:39–47.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost. 2009;7(Suppl 1):44–48.
   PubMed Web of Science ®Google Scholar
• Ostermann AI, Schebb NH. Effects of omega-3 fatty acid supplementation on the pattern of oxylipins: a short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids. Food Funct. 2017;8:2355–2367.
   PubMed Web of Science ®Google Scholar
• Chiang N, Fredman G, Backhed F, et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012;484:524–528.
   PubMed Web of Science ®Google Scholar
• Fredman G, Hellmann J, Proto JD, et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat Commun. 2016;7:12859.
   PubMed Web of Science ®Google Scholar
• Sham HP, Walker KH, Abdulnour RE, et al. 15-Epi-lipoxin a4, resolvin d2, and resolvin d3 induce NF-κB regulators in bacterial pneumonia. J Immunol. 2018;200:2757–2766.
   PubMed Web of Science ®Google Scholar
• Titos E, Rius B, Lopez-Vicario C, et al. Signaling and immunoresolving actions of resolvin d1 in inflamed human visceral adipose tissue. J Immunol. 2016;197:3360–3370.
   PubMed Web of Science ®Google Scholar
• Lands B. Highly unsaturated fatty acids (HUFA) mediate and monitor food’s impact on health. Prostaglandins Other Lipid Mediat. 2017;133:4–10.
   PubMed Web of Science ®Google Scholar
• Adarme-Vega TC, Thomas-Hall SR, Schenk PM. Towards sustainable sources for omega-3 fatty acids production. Curr Opin Biotechnol. 2014;26:14–18.
   PubMed Web of Science ®Google Scholar
• Lands B, Bibus D, Stark KD. Dynamic interactions of n-3 and n-6 fatty acid nutrients. Prostaglandins Leukot Essent Fatty Acids. 2018;136:15–21.
   PubMed Web of Science ®Google Scholar
• Harris WS. The omega-6:omega-3 ratio: A critical appraisal and possible successor. Prostaglandins Leukot Essent Fatty Acids. 2018;132:34–40.
   PubMed Web of Science ®Google Scholar
• Walker RE, Jackson KH, Tintle NL, et al. Predicting the effects of supplemental EPA and DHA on the omega-3 index. Am J Clin Nutr. 2019;110:1034–1040.
   PubMed Web of Science ®Google Scholar
• EFSA Panel on Dietetic Products N, Allergies. Scientific Opinion on the extension of use for DHA and EPA-rich algal oil from Schizochytrium sp. as a Novel Food ingredient. EFSA J. 2014;12:3843.
   Google Scholar
• Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75:645–662.
   PubMed Web of Science ®Google Scholar
• von Schacky C. Confusion about the effects of omega-3 fatty acids: contemplation of study data taking the omega-3 index into consideration. Internist (Berl). 2019;60:1319–1327.
   PubMed Web of Science ®Google Scholar
• Wang T, Marken J, Chen J, et al. High TLR7 expression drives the expansion of CD19 + CD24hiCD38hi transitional B cells and autoantibody production in SLE patients. Front Immunol. 2019;10:1243.
   PubMed Web of Science ®Google Scholar
• Henjes F, Lourido L, Ruiz-Romero C, et al. Analysis of autoantibody profiles in osteoarthritis using comprehensive protein array concepts. J Proteome Res. 2014;13:5218–5229.
   PubMed Web of Science ®Google Scholar
• Arai S, Maehara N, Iwamura Y, et al. Obesity-associated autoantibody production requires AIM to retain the immunoglobulin M immune complex on follicular dendritic cells. Cell Rep. 2013;3:1187–1198.
   PubMed Web of Science ®Google Scholar
• Li QZ, Karp DR, Quan J, et al. Risk factors for ANA positivity in healthy persons. Arthr Res Ther. 2011;13:R38.
   PubMed Web of Science ®Google Scholar
• Li QZ, Zhou J, Wandstrat AE, et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol. 2007;147:60–70.
   PubMed Web of Science ®Google Scholar
• Packard TA, Li QZ, Cosgrove GP, et al. COPD is associated with production of autoantibodies to a broad spectrum of self-antigens, correlative with disease phenotype. Immunol Res. 2013;55:48–57.
   PubMed Web of Science ®Google Scholar
• Martinez J, Cunha LD, Park S, et al. Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells. Nature. 2016;533:115–119.
   PubMed Web of Science ®Google Scholar
• Cao Q, Zhao X, Bai J, et al. Circadian clock cryptochrome proteins regulate autoimmunity. Proc Natl Acad Sci USA. 2017;114:12548–12553.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yu M, Zheng Y, et al. CXCR5 + PD-1+ follicular helper CD8 T cells control B cell tolerance. Nat Commun. 2019;10:4415.
   PubMed Web of Science ®Google Scholar
• Preite S, Cannons JL, Radtke AJ, et al. Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity. Nat Immunol. 2018;19:986–1000.
   PubMed Web of Science ®Google Scholar